Precision Colorectal Cancer Fecal Immunological Test Screening With Fecal-Hemoglobin-Concentration–Guided Interscreening Intervals

Authors:

Abstract
Over the course of recent decades, significant strides have been taken to ameliorate the menace of colorectal cancer (CRC), a malignant disease ranking as the third most widespread across the globe. This progress is attributed to the implementation of population-based screening programs geared toward the early detection of CRC, in tandem with advancements in therapeutic modalities. Among the array of instruments harnessed within these screening initiatives, the fecal immunochemical test (FIT), a prominent stool-based diagnostic tool, has emerged as a pivotal determinant in curbing CRC mortality rates.1-4

This publication has 27 references indexed in Scilit: